Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutant Prevention Concentration and Mutant Selection Window of Micafungin and Anidulafungin in Clinical Candida glabrata Isolates.

Antimicrobial agents and chemotherapy - 1 Mar 2018

Bordallo-Cardona María Ángeles, Marcos-Zambrano Laura Judith, Sánchez-Carrillo Carlos, de la Pedrosa Elia Gómez G, Cantón Rafael, Bouza Emilio, Escribano Pilar, Guinea Jesús

Abstract excerpt

We report the mutant prevention concentration (MPC) and mutant selection window (MSW) for micafungin and anidulafungin administered to treat Candida glabrata We also determine the mutation frequency. We studied 20 echinocandin-susceptible, fluconazole-intermediate, and FKS wild-type C. glabrata isolates. Adjusted inocula were stroked directly onto Sabouraud agar plates containing different concentrations of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal Agents
Share to Candida glabrata

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Fungal

Share to Echinocandins

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 29311063
DOI: 10.1128/AAC.01982-17
PMCID: PMC5826129

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutant Prevention Concentration and Mutant Selection Window of Micafungin and Anidulafungin in Clinical Candida glabrata Isolates.PMID 29311063Read ↗

Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata.Semantic proximity Read ↗

Candida glabrata mutants demonstrating paradoxical reduced caspofungin susceptibility but increased micafungin susceptibility.Semantic proximity Read ↗

Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates.Semantic proximity Read ↗

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance.Semantic proximity Read ↗

Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations.Semantic proximity Read ↗

FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.Semantic proximity Read ↗

Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.Semantic proximity Read ↗

Clinical perspectives on echinocandin resistance among Candida species.Semantic proximity Read ↗

In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates.Semantic proximity Read ↗

Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method.Semantic proximity Read ↗

Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.Semantic proximity Read ↗

Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.